Lighthouse Pharmaceuticals Closes $12 Million Series A Financing Led by Double Point Ventures

NOVATO, Calif., April 28, 2026 /PRNewswire/ -- Lighthouse Pharmaceuticals, a clinical-stage biopharmaceutical company developing novel small-molecule therapies for neurodegenerative and inflammatory diseases, today announced the closing of a $12 million Series A financing led by Double...